Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: Implications for gene therapeutic approaches

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cgt.7700106PMID 10678363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human gene marker/therapy clinical protocols.

  1999cited by this paper
• Mode of Action of (1′S,2′R)-9-{[1′,2′-Bis(hydroxymethyl) cycloprop-1′-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus

  1998cited by this paper
• Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing.

  1998cited by this paper
• Taming the sinister side of BMT: Dr. Jekyll and Mr. Hyde

  1997cited by this paper
• Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

  1997cited by this paper
• HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

  1997cited by this paper
• Suicide genes and bystander killing: local and distant effects

  1997cited by this paper
• Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.

  1997cited by this paper
• A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs.

  1997cited by this paper
• Solution structure of a DNA decamer containing the antiviral drug ganciclovir: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement.

  1997cited by this paper
• Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

  1996cited by this paper
• Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues.

  1996cited by this paper
• Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins.

  1996cited by this paper
• Segregation of DNA polynucleotide strands into sister chromatids and the use of endoreduplicated cells to track sister chromatid exchanges induced by crosslinks, alkylations, or x-ray damage.

  1996cited by this paper
• Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.

  1996cited by this paper
• Ganciclovir.

  1996cited by this paper
• Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect".

  1996cited by this paper
• Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action.

  1995cited by this paper
• A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

  1995cited by this paper
• In search of the perfect antiviral

  1995cited by this paper
• Chiral chemical synthesis of DNA containing (S)-9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) and effects on thermal stability, duplex structure, and thermodynamics of duplex formation.

  1995cited by this paper
• Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

  1994cited by this paper
• A history of antiherpes research

  1994cited by this paper
• Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.

  1993cited by this paper
• A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

  1993cited by this paper
• The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

  1993cited by this paper
• Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health

  1993cited by this paper
• The Mode of Action of Penciclovir

  1993cited by this paper
• Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to Penciclovir

  1993cited by this paper
• Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Stress factors affecting expression of O6-methylguanine-DNA methyltransferase mRNA in rat hepatoma cells.

  1992cited by this paper
• Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir

  1991cited by this paper
• Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.

  1991cited by this paper
• Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition.

  1989cited by this paper
• Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.

  1988cited by this paper
• Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information

  1987cited by this paper
• Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

  1986cited by this paper
• Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.

  1985cited by this paper
• Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.

  1985cited by this paper

• RAD18‐ and BRCA1‐dependent pathways promote cellular tolerance to the nucleoside analog ganciclovir

  2024cites this paper
• Optimization of Thymidine Kinase-Based Safety Switch for Neural Cell Therapy

  2022cites this paper
• Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies

  2022cites this paper
• Alteration of mitochondrial DNA homeostasis in drug-induced liver injury.

  2020cites this paper
• Herpesvirus Polymerase Inhibitors

  2019cites this paper
• Optimum treatment of congenital cytomegalovirus infection

  2016cites this paper
• Alterations of Mitochondrial DNA in Liver Diseases

  2015cites this paper
• Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment

  2015cites this paper
• Regulation and function of adult neurogenesis: from genes to cognition.

  2014cites this paper
• Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy.

  2014cites this paper
• Outflow tract ablation using a conditionally cytotoxic feline immunodeficiency viral vector.

  2014cites this paper
• Human herpes simplex virus: Life cycle and development of inhibitors

  2014cites this paper
• Gene-Directed Enzyme Prodrug Cancer Therapy

  2013cites this paper
• Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.

  2013cites this paper
• SEARCH OF INHIBITORS OF HERPES VIRAL REPLICATION: 30 YEARS AFTER ACYCLOVIR

  2013cites this paper
• Synthesis of GnRH analogues and their application in targeted gene delivery systems

  2012cites this paper
• Central role of mitochondria in drug-induced liver injury

  2012influential citation
• Unrepairable DNA Double Strand Breaks Initiate Cytotoxicity with HSV-TK/Ganciclovir

  2011cites this paper
• Targeted Cytosine Deaminase-Uracil Phosphoribosyl Transferase Suicide Gene Therapy Induces Small Cell Lung Cancer–Specific Cytotoxicity and Tumor Growth Delay

  2010cites this paper
• Mitochondrial involvement in drug-induced liver injury.

  2010cites this paper
• Selective Suicide Gene Therapy of Colon Cancer Cell Lines Exploiting Fibroblast Growth Factor 18 Promoter

  2010cites this paper
• Selective Suicide Gene Therapy of Colon Cancer Exploiting the Urokinase Plasminogen Activator Receptor Promoter

  2010cites this paper
• Alteration of the carbohydrate for deoxyguanosine analogs markedly changes DNA replication fidelity, cell cycle progression and cytotoxicity.

  2010cites this paper
• Gene and Virotherapy Against Osteosarcoma

  2009cites this paper
• Modification of adenovirus capsid proteins for gene therapy applications

  2009cites this paper
• Specifically targeted gene therapy for small-cell lung cancer

  2009cites this paper
• The Role of DNA Damage and Repair in Ganciclovir-mediated Cytotoxicity.

  2008cites this paper
• Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy

  2008cites this paper
• Replication‐competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment

  2007cites this paper
• Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.

  2007cites this paper
• Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes

  2007cites this paper
• Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.

  2007cites this paper
• Hurdles and Improvements in Therapeutic Gene Transfer for Cancer

  2007cites this paper
• StpC-based gene therapy targeting latent reservoirs of HIV-1.

  2006cites this paper
• Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.

  2006cites this paper
• Introduction to the background, principles, and state of the art in suicide gene therapy

  2005cites this paper
• Biochemical and Structural Characterization of (South)-Methanocarbathymidine That Specifically Inhibits Growth of Herpes Simplex Virus Type 1 Thymidine Kinase-transduced Osteosarcoma Cells*

  2004cites this paper
• Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells.

  2004cites this paper
• Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8.

  2003cites this paper
• Gene Therapy of Ovarian Cancer—State-of-the-Art and Future Perspectives

  2003cites this paper
• The thymidine kinase of Epstein-Barr virus and herpes simplex virus and their application as suicide genes

  2003cites this paper
• Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.

  2003cites this paper
• Liver Failure Caused by Herpes Simplex Virus Thymidine Kinase Plus Ganciclovir Therapy Is Associated with Mitochondrial Dysfunction and Mitochondrial DNA Depletion

  2003cites this paper
• Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)

  2003cites this paper
• DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling.

  2003cites this paper
• Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation

  2002influential citation
• Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies.

  2002cites this paper
• [Genetic therapy of cancer].

  2002cites this paper
• Development of a novel enzyme/prodrug system for hypoxia- and radiation-mediated gene therapy of cancer.

  2002cites this paper
• Optimizing Prostate Cancer Suicide Gene Therapy Using Herpes Simplex Virus Thymidine Kinase Active Site Variants

  2002cites this paper
• Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir.

  2002cites this paper
• Hamster Bcl-2 protein is cleaved in vitro and in cells by caspase-9 and caspase-3.

  2001cites this paper
• Genetic risks of antiviral nucleoside analogues--a survey.

  2001cites this paper
• DNA double-strand breaks trigger apoptosis in p53-deficient fibroblasts.

  2001cites this paper
• Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives

  2001cites this paper
• against Ganciclovir-induced Cytotoxicity and DNA Breakage Mediates Protection of Mammalian Cells β DNA Polymerase Updated

  2001cites this paper
• A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates.

  2001cites this paper
• Cloning and functional analysis of cDNA encoding the hamster Bcl-2 protein.

  2000cites this paper
• Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir.

  2000cites this paper